This miRNA shortens the disease-free survival time in lung cancer patients with high expression levels [15] or the inhibition of PTEN by miR-494-3p, leading to the activation of Akt in nasal natural killer cell lymphoma [35]. The gene discussed is PTEN; the disease is lung cancer.